Procedure for Stability Testing of Ophthalmic Products

1) Purpose

The purpose of this SOP is to establish a standardized procedure for conducting stability testing on ophthalmic drug products in compliance with relevant regulatory guidelines. This ensures that these products maintain their quality, safety, and efficacy throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of ophthalmic products, including formulation development, quality control, and regulatory affairs teams.

3) Responsibilities

Formulation Development Team: Responsible for developing ophthalmic formulations and selecting suitable packaging materials.
Stability Study Team: Responsible for conducting stability studies as per the approved protocol.
Quality Assurance Team: Responsible for reviewing data for compliance with regulatory requirements.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol in compliance with regulatory guidelines, including specifications for sterility, pH, viscosity, and preservative content.

4.1.2 Define testing intervals and storage conditions (e.g., refrigerated,

“Unveiling the Untold: Innovatively Reliable HPLC Methods for Drug Analysis Ensuring Stability and Quality Assurance”

4.2 Sample Preparation and Storage

4.2.1 Prepare samples in their final packaging.

4.2.2 Store samples under specified conditions for long-term and accelerated studies.

4.3 Conducting Stability Tests

4.3.1 Perform stability tests at predefined intervals to evaluate product quality over time.

4.3.2 Record all data accurately and document any deviations.

4.4 Data Analysis and Reporting

4.4.1 Analyze the stability